We are proud of our achievements and want to share our successes. You can find the latest information on our projects, publications, and events here.

Filter by:

NEWS

20 August 2018
TIKOMED to initiate ALS clinical trial for which the UK Medicines and Healthcare products Regulatory Agency has granted permission
Viken, August 20th, 2018 — TIKOMED, a specialty pharmaceutical company focused on developing therapeutics for…
Read More
14 August 2018
TIKOMED Announce Start of ALS Study at Sahlgrenska University Hospital
VIKEN, Sweden, August 14, 2018 – ​TIKOMED, a specialty pharmaceutical company focused on developing therapeutics…
Read More
24 July 2018
TIKOMED is looking for an experienced Project Leader
We are looking for you who are passionate, skilled and with strong track record and…
Read More
5 July 2018
Tikomed granted permission for clinical trial in ALS by the Swedish Medical Product Agency and Ethical Review Board.
Viken, May 28th, 2018 TikoMed, a specialty pharmaceutical company focused on developing therapeutics for treating…
Read More
5 July 2018
ILB – A game changer in Glaucoma
Viken, May 22nd, 2018 TikoMed, a specialty pharmaceutical company that focuses on developing therapeutics for…
Read More
5 June 2018
Anders Kristensson appointed CEO of TikoMed
Viken – 18th June 2018 TikoMed, a privately-held biopharmaceutical company today announced the appointment of…
Read More
27 April 2018
TIKOMED IS INTERVIEWED BY RAPIDUS
TikoMed fyller kassan inför ALS-studier 2018-04-23 Läkemedelsbolaget TikoMed från skånska Viken fyller på kassan med…
Read More
22 April 2018
TIKOMED IS INTERVIEWED AT BIOSPRING ABOUT IBSOLVMIR FOR IMPROVED CELL-THERAPIES BY MIKE WARD
TikoMeds promising Phase 2 project for more efficient cell-therapies was presented at BioEurope Spring in…
Read More
26 March 2018
TIKOMED CEO IS PANELIST AT EUROPE CEO IN AMSTERDAM
TikoMeds CEO represented TikoMed at the Europe CEO meeting prior to the BIO Europe spring…
Read More
22 March 2018
TIKOMED PRESENTS IBSOLVMIR AT BIO EUROPE
IBsolvMIR is TikoMed’s original project addressed at alleviating the ”Instant Blood Mediated Inflammatory Reaction” that…
Read More
24 December 2017
TIKOMED CEO WILL BE MODERATING THE ”EVOLVING BIOPHARMA BOARDS” AT THE EAST/WEST CEO MEETING PRECEEDING JPMORGAN HEALTH CONFERENCE
Adam Bruce, CEO of TikoMed will be moderating the ”Evolving Biopharma Boards” panel discussion at…
Read More

EVENTS

TIKOMED WILL SPEAK AT BIOTECH IN EUROPE FORUM
Date: 4 October 2018 - 5 October 2018
Venue: Congress Center
Read More
TIKOMED WILL BE SENDING TEAM TO BIO-EUROPE
Date: 5 November 2018 - 7 November 2018
Venue: Bella Center
Read More

SUBSCRIBE